Nano based approach for the treatment of neglected tropical diseases
Neglected tropical diseases (NTDs) afflict more than one billion peoples in the world's
poorest countries. The World Health Organization (WHO) has recorded seventeen NTDs in …
poorest countries. The World Health Organization (WHO) has recorded seventeen NTDs in …
Nanomedicine-based strategies to improve treatment of cutaneous leishmaniasis
N Goonoo, MA Laetitia Huët… - Royal Society …, 2022 - royalsocietypublishing.org
Nanomedicine strategies were first adapted and successfully translated to clinical
application for diseases, such as cancer and diabetes. These strategies would no doubt …
application for diseases, such as cancer and diabetes. These strategies would no doubt …
Licochalcone A-Loaded Solid Lipid Nanoparticles Improve Antischistosomal Activity In Vitro and In Vivo
LM Silva, DG Marconato, MP Nascimento da Silva… - …, 2021 - Taylor & Francis
Aim: To isolate licochalcone A (LicoA) from licorice, prepare LicoA-loaded solid lipid
nanoparticles (L-SLNs) and evaluate the L-SLNs in vitro and in vivo against Schistosoma …
nanoparticles (L-SLNs) and evaluate the L-SLNs in vitro and in vivo against Schistosoma …
Alkyl and Aryl Derivatives Based on p-Coumaric Acid Modification and Inhibitory Action against Leishmania braziliensis and Plasmodium falciparum
In low-income populations, neglected diseases are the principal cause of mortality. Of these,
leishmaniasis and malaria, being parasitic, protozoan infections, affect millions of people …
leishmaniasis and malaria, being parasitic, protozoan infections, affect millions of people …
Chitosan-based particulate systems for drug and vaccine delivery in the treatment and prevention of neglected tropical diseases
Neglected tropical diseases (NTDs) are a diverse group of infections which are difficult to
prevent or control, affecting impoverished communities that are unique to tropical or …
prevent or control, affecting impoverished communities that are unique to tropical or …
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
MM Eissa, MZ El-Azzouni, LK El-Khordagui… - Parasites & vectors, 2020 - Springer
Background The control of schistosomiasis has been centered to date on a single drug,
praziquantel, with shortcomings including treatment failure, reinfection, and emergence of …
praziquantel, with shortcomings including treatment failure, reinfection, and emergence of …
Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review
D Dourado, TS Medeiros… - Beilstein Journal of …, 2024 - beilstein-journals.org
Leishmaniasis is a neglected tropical disease that has affected more than 350 million
people worldwide and can manifest itself in three different forms: cutaneous …
people worldwide and can manifest itself in three different forms: cutaneous …
Impact of nanoparticles on protozoa
D Plachá, J Jampílek - Nanotechnology in Medicine: Toxicity …, 2021 - Wiley Online Library
Protozoa (unicellular eukaryotes) are wild or parasitic organisms that feed on organic matter,
such as other microorganisms or organic tissues and debris. Protozoans have historically …
such as other microorganisms or organic tissues and debris. Protozoans have historically …
Experimental treatment of Schistosomiasis mansoni using praziquantel-free and encapsulated into nanostructures
LN Andrade, DS Oliveira, JG Galvão… - … for Neglected Tropical …, 2021 - Elsevier
Schistosomiasis is a tropical disease spread in more than 54 countries affecting 261 million
people around the world. This disease is considered neglected due to socioeconomic and …
people around the world. This disease is considered neglected due to socioeconomic and …
Nanotechnology-based Approaches for the Treatment of Toxocariasis: A Prospective Review
A Jahanmahin, H Borji - Journal of Veterinary Physiology and …, 2023 - jvpp.rovedar.com
Toxocariasis, caused by Toxocara parasites, is a prevalent parasitic disease affecting
millions of people worldwide. Conventional anthelmintic drugs for toxocariasis face …
millions of people worldwide. Conventional anthelmintic drugs for toxocariasis face …